Session(s)
- A Global Evaluation of Agreement on the Decision to Perform Surgical Lung Biopsy Between P...
Sunday, May 20 9:15 AM - 11:15 AM - Association of Angiotensin Modulators with the Course of Idiopathic Pulmonary Fibrosis [Bo...
Sunday, May 20 11:15 AM - 1:00 PM - Comparison of mRNA and miRNA Expression in Endobronchial Epithelial Lining Fluid and Bronc...
Sunday, May 20 11:15 AM - 1:00 PM - Correlation of Functional Assessment and CT Scores in Acute Exacerbations in Patients with...
Sunday, May 20 11:15 AM - 1:00 PM - Diagnosis and Management of Patients with Interstitial Lung Disease (ILD) in Clinical Prac...
Sunday, May 20 11:15 AM - 1:00 PM - Gastrointestinal Adverse Events with Nintedanib with Add-On Pirfenidone in Patients with I...
Sunday, May 20 11:15 AM - 1:00 PM - Impact of Lung Function Decline on Health-Related Quality of Life in Patients with Idiopat...
Sunday, May 20 11:15 AM - 1:00 PM - Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey [Boa...
Sunday, May 20 11:15 AM - 1:00 PM - Pirfenidone in Patients with Unclassifiable Progressive Fibrosing Interstitial Lung Diseas...
Sunday, May 20 11:15 AM - 1:00 PM - Efficacy and Safety of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary...
Sunday, May 20 3:45 PM - 4:00 PM - Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease...
Monday, May 21 2:15 PM - 4:15 PM - Exacerbations, Hospitalisations and Mortality in Patients with Idiopathic Pulmonary Fibros...
Tuesday, May 22 9:15 AM - 11:15 AM - Financial Burden of Interstitial Lung Disease -a Claims Data Based Study [Board No. P138]
Tuesday, May 22 11:15 AM - 1:00 PM